Dr. Jonathan Beaux Lin, MD, PhD

Dr. Lin practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Lin's NPI, 1518586759, was assigned on April 8, 2020. Dr. Lin graduated from WashU Medicine in 2020. Dr. Lin holds California license A195773.

Dr. Lin's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Lin's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Lin to 1 more hospital and 2 medical groups, each named with a free account. Dr. Lin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Lin's licenses on file in 2 states: California and Massachusetts.

CMS data shows 18 Medicare services from Dr. Lin across 1 procedure code in 2024, all of them office visits, for 28 Medicare patients. Medicare paid $1,069 for them. Every service was in an office.

CMS counts 28 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 60, with 55% women.

In 2024, Dr. Lin wrote 197 Medicare Part D claims for 112 patients. 58% of them were for generic drugs. CMS names the drug for 92 of them, across 3 drugs with 11 or more claims each, at $2,930 in total drug cost. In 2023, CMS named 55 claims across 3 drugs.

Dmand AI links 35 papers to Dr. Lin, published from 2016 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Glaucoma, Retina and Macular Degeneration. Dr. Lin has published most often in Ophthalmol Sci. Dr. Lin's most frequent co-authors are Rajendra Shridhar Apte, MD, Kristine T. Lo, MD and Christian E. Song, MD.

CMS Open Payments shows 8 general payments to Dr. Lin from 4 drug and device companies from 2024 to 2025. Travel and lodging make up the largest share, 52% of the total. Alcon Laboratories Inc paid the most, $992.

Dr. Lin graduated from WashU Medicine in 2020.

Dr. Lin is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.